Suppr超能文献

脓毒性休克治疗中的液体与早期血管加压药:我们找到正确答案了吗?

Fluids and Early Vasopressors in the Management of Septic Shock: Do We Have the Right Answers Yet?

作者信息

Carlos Sanchez E, Pinsky Michael R, Sinha Sharmili, Mishra Rajesh Chandra, Lopa Ahsina Jahan, Chatterjee Ranajit

机构信息

Department of Critical Care Medicine, King Salman Hospital, Riyadh, Saudi Arabia.

Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

出版信息

J Crit Care Med (Targu Mures). 2023 Jul 31;9(3):138-147. doi: 10.2478/jccm-2023-0022. eCollection 2023 Jul.

Abstract

Septic shock is a common condition associated with hypotension and organ dysfunction. It is associated with high mortality rates of up to 60% despite the best recommended resuscitation strategies in international guidelines. Patients with septic shock generally have a Mean Arterial Pressure below 65 mmHg and hypotension is the most important determinant of mortality among this group of patients. The extent and duration of hypotension are important. The two initial options that we have are 1) administration of intravenous (IV) fluids and 2) vasopressors, The current recommendation of the Surviving Sepsis Campaign guidelines to administer 30 ml/kg fluid cannot be applied to all patients. Complications of fluid over-resuscitation further delay organ recovery, prolong ICU and hospital length of stay, and increase mortality. The only reason for administering intravenous fluids in a patient with circulatory shock is to increase the mean systemic filling pressure in a patient who is volume-responsive, such that cardiac output also increases. The use of vasopressors seems to be a more appropriate strategy, the very early administration of vasopressors, preferably during the first hour after diagnosis of septic shock, may have a multimodal action and potential advantages, leading to lower morbidity and mortality in the management of septic patients. Vasopressor therapy should be initiated as soon as possible in patients with septic shock.

摘要

感染性休克是一种与低血压和器官功能障碍相关的常见病症。尽管国际指南推荐了最佳的复苏策略,但它的死亡率仍高达60%。感染性休克患者的平均动脉压通常低于65 mmHg,低血压是这类患者死亡率的最重要决定因素。低血压的程度和持续时间很重要。我们最初的两种选择是:1)静脉输液;2)血管升压药。脓毒症存活策略指南中目前推荐的给予30 ml/kg液体的方法并不适用于所有患者。液体过度复苏的并发症会进一步延迟器官恢复,延长重症监护病房(ICU)和住院时间,并增加死亡率。在循环性休克患者中静脉输液的唯一目的是增加对容量有反应的患者的平均体循环充盈压,从而使心输出量也增加。使用血管升压药似乎是一种更合适的策略,尽早使用血管升压药,最好是在诊断感染性休克后的第一小时内使用,可能具有多模式作用和潜在优势,从而降低脓毒症患者管理中的发病率和死亡率。对于感染性休克患者,应尽快开始血管升压药治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be4/10425929/a7c0231c1430/j_jccm-2023-0022_fig_001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验